C

CALVIRI

14 employees

Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.

Basic info

Industry

biotechnology research

Sectors

dog trial
Neoantigens
Biotechnology
Peptides
Diagnostics
cancer vaccines
Science
Oncology
Vaccines
research
Prevention
Marc Wolff
Prophylactic
cancervaccines
early cancer detection
Biotech
Calviri
Therapeutic
Stephen Albert Johnston
Health Diagnostics
Therapeutics
Healthcare
ICI diagnostic
Veterinary
Arrays
Startup

Date founded

2018

FAQ